Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Oncology

Understanding Your MTC Pathology Report

At a Glance

Your MTC pathology report determines how aggressive your cancer is using the IMTCGS grading system. A tumor is considered high-grade if it has a high mitotic count, a Ki-67 index of 5% or more, or tumor necrosis. Understanding these terms helps you and your doctor plan your follow-up care.

Your pathology report is the definitive “technical manual” for your cancer. While your surgeon sees the tumor during the operation, the pathologist is the one who looks at the cells under a microscope to determine how the cancer is likely to behave in the future.

In recent years, the way Medullary Thyroid Carcinoma (MTC) is reported has changed significantly. You should audit your report to ensure it contains the most current and relevant information.

The International MTC Grading System (IMTCGS)

The 2022 World Health Organization guidelines introduced a new, standardized way to “grade” MTC. This system, known as the IMTCGS, categorizes your tumor as either Low-Grade or High-Grade based on how fast the cells are dividing and whether they are dying off [1].

A tumor is classified as High-Grade if it meets at least one of the following criteria [2][3]:

  • Mitotic Count: There are 5 or more “mitoses” (cells in the act of dividing) seen in a specific 2mm² area.
  • Ki-67 Index: This is a special stain that measures the percentage of cells actively growing. A Ki-67 index of 5% or higher is considered high-grade [2].
  • Tumor Necrosis: This refers to areas of “coagulative necrosis,” where cancer cells have died off because the tumor is outgrowing its blood supply. This is a strong indicator of aggressive behavior [3].

Note on Ki-67 ≥20%: If your report shows a Ki-67 index of 20% or higher, it identifies a specific subgroup that may require more intensive monitoring or aggressive treatment, as this level is associated with the highest risk of recurrence [2][4].

Key Prognostic Variables

Beyond the grade, several other factors on your report determine your “stage” and long-term outlook:

  • TNM Staging: This stands for Tumor size, Node involvement, and Metastasis (spread). A higher “pT” (pathologic tumor) or “pN” (pathologic node) stage generally correlates with a higher risk of distant spread [4].
  • Lymph Node Ratio (LNR): This is one of the most important numbers on your report [5]. It is calculated by dividing the number of positive lymph nodes by the total number of nodes removed. For example, if 10 nodes were removed and 5 were positive, your LNR is 0.50. A higher LNR is an independent predictor that the cancer may be more likely to return or spread [6].
  • Vascular Invasion: This tells you if cancer cells have begun to “tunnel” into the blood vessels within or around the thyroid.
  • Extrathyroidal Extension (ETE): This indicates if the tumor has grown beyond the “capsule” or outer edge of the thyroid and into the surrounding tissues.

Pathology Report Completeness Checklist

According to professional standards, a complete and high-quality report should use a “synoptic” (checklist) format and MUST include [1]:

  • [ ] Tumor Size: The maximum diameter of the primary tumor.
  • [ ] Margins: Whether the edges of the removed tissue are clear of cancer.
  • [ ] Mitotic Count: The number of cells dividing per 2mm².
  • [ ] Necrosis: Explicitly stating if necrosis is present or absent.
  • [ ] Ki-67 Index: The percentage of cells staining positive for growth.
  • [ ] Lymph Node Status: The total number of nodes found and the number that contain cancer.
  • [ ] Vascular Invasion: Present or absent.
  • [ ] Extrathyroidal Extension: Present or absent.

Common questions in this guide

What does a high-grade MTC tumor mean?
A high-grade medullary thyroid carcinoma means the tumor cells are dividing quickly or dying off. This is determined using the IMTCGS grading system, which looks at the mitotic count, Ki-67 index, and tumor necrosis.
What is a Ki-67 index on my thyroid pathology report?
The Ki-67 index is a special test that measures the percentage of cancer cells actively growing. In MTC, a Ki-67 index of 5% or higher is considered high-grade, and a score of 20% or higher suggests the highest risk of recurrence.
What does tumor necrosis mean?
Tumor necrosis means that some cancer cells have died because the tumor is outgrowing its blood supply. Finding coagulative necrosis on your pathology report is a strong indicator of more aggressive tumor behavior.
Why is the lymph node ratio (LNR) important?
The lymph node ratio is calculated by dividing the number of positive lymph nodes by the total number of nodes removed during surgery. A higher ratio is an independent predictor that the cancer may be more likely to return or spread.
What is extrathyroidal extension (ETE)?
Extrathyroidal extension means the tumor has grown beyond the outer capsule of the thyroid gland and into the surrounding healthy tissues.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the final grade of my tumor according to the International Medullary Thyroid Carcinoma Grading System (IMTCGS)?
  2. 2.Was my Ki-67 index specifically measured, and is it above or below the 5% and 20% thresholds?
  3. 3.Was any 'coagulative necrosis' found within the tumor, and what does that mean for my follow-up plan?
  4. 4.What is my Lymph Node Ratio (LNR), and does it suggest a higher risk of the cancer returning?
  5. 5.Does my report show any signs of vascular invasion or extrathyroidal extension?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (6)
  1. 1

    International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.

    Xu B, Fuchs TL, Ahmadi S, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022; (40(1)):96-104 doi:10.1200/JCO.21.01329.

    PMID: 34731032
  2. 2

    Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases.

    Porcelli T, Moog S, Bani MA, et al.

    Thyroid : official journal of the American Thyroid Association 2025; (35(11)):1268-1276 doi:10.1177/10507256251388028.

    PMID: 41153085
  3. 3

    A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis.

    Fuchs TL, Nassour AJ, Glover A, et al.

    The American journal of surgical pathology 2020; (44(10)):1419-1428 doi:10.1097/PAS.0000000000001505.

    PMID: 32452872
  4. 4

    Immunohistochemical expression of Ki-67, INSM1, and SSTR2A in medullary thyroid carcinoma: correlation with tumour size, vascular invasion, and biochemical outcome.

    Rossi ED, Raia S, Maratta M, et al.

    Virchows Archiv : an international journal of pathology 2025; doi:10.1007/s00428-025-04287-z.

    PMID: 41136787
  5. 5

    The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.

    Rozenblat T, Hirsch D, Robenshtok E, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2020; (46(11)):2023-2028 doi:10.1016/j.ejso.2020.04.016.

    PMID: 32389525
  6. 6

    Predictors of Distant Metastasis in Patients with Medullary Thyroid Carcinoma.

    Ros-Madrid I, Febrero B, Cano-Mármol RP, et al.

    Cancers 2025; (17(19)) doi:10.3390/cancers17193193.

    PMID: 41097721

This page explains MTC pathology terminology for educational purposes. Always discuss your specific pathology report and IMTCGS grade with your oncologist or endocrinologist to understand your prognosis.

Get notified when new evidence is published on Medullary thyroid carcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.